我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 宇宙IF
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Sympathetic Ganglion Block and Neridronate Infusion for Early Phase CPRS-I Treatment: Effects on Pain and Microcirculation

Gagliardi G and Ceccherelli F

CRPS can be described as a painful inflammatory condition that occurs in most cases after a traumatic lesion,
such as sprain or fracture. The main physiopathological elements involved in the genesis of CPRS-I are essentially:
autonomical nervous system activity, neurogenic inflammation and microvascular impairment. The aim of the study is
to investigate the effect of an integrated treatment, which consists of an anesthetic block of the sympathetic lumbar
chain and a neridronate infusion protocol, on pain and microcirculatory variations in patients affected by CPRS of lower
limb. Twelve patients affected by early stage CPRS-I with a duration of pain of 3 ± 1.2 months have been enrolled. They
have been treated with a neridronate infusion of 100 mg × 4 times over 10 days; and simultaneously, they underwent
an ipsilateral lumbar sympathetic nerve block. Pain intensity, function restoration and analisys of microcirculation using the LDF (laser doppler flowmeter) have been monitored. The results have shown a quick clinical improvement, with a reduction in pain severity and a restoration of microcirculation function. The association of neridornate infusion and sympathetic nerve block has been found to be effective and safe for early stage CPRS-I treatment.